Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Berubicin Hydrochloride
Therapeutic Area : Oncology
Study Phase : Phase I
Recipient : CNS Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
CNS Pharmaceuticals Begins Manufacturing of Berubicin in Europe
Details : Company's European manufacturer, BSP Pharmaceuticals S.p.A, has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme, an aggressive form of brain cancer currently considered incu...
Product Name : Undisclosed
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
September 10, 2020
Lead Product(s) : Berubicin Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Phase I
Recipient : CNS Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
